Overview

Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)

Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema
Phase:
Phase 1
Details
Lead Sponsor:
Ocugen